Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

‍

In the United Kingdom, a phase 3 clinical trial is researching a 50-year-old drug found in cough medicine, ambroxol, as a treatment for Parkinson's disease. Studies indicate ambroxol helps clear alpha-synuclein, a toxic protein known to cause Parkinson's. (New Atlas)

IMA Group purchased Clinical Trials of America (CTA) for an undisclosed amount. CTA operates over a dozen locations in North Carolina and Louisiana. (Fierce Biotech)

Jessica Davis examines the FDA's new authorities over medical device security, and what that means for manufacturers. (SC Magazine)

The 14th annual SCOPE Summit 2023, will take place February 6–9, 2023, in Orlando, Florida, where the clinical research community gathers to discuss continued innovation and collaboration. Team AG Mednet will be there!

‍
‍

Our Culture

“The Judi platform is purpose-built to drive clinical trial success—cloud-based, secure, collaborative. Our greatest strength, above all else, is our people."

   –Abraham Gutman, President and CEO

‍‍
‍

About Judi

Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.

‍

‍

‍

‍